| Stereochemistry | RACEMIC |
| Molecular Formula | C17H25NO.ClH |
| Molecular Weight | 295.847 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
InChI
InChIKey=GTAXGNCCEYZRII-UHFFFAOYSA-N
InChI=1S/C17H25NO.ClH/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18;/h7-10,14H,3-6,11-13H2,1-2H3;1H
Eperisone is an antispasmodic drug approved in Japan for the treatment of of diseases characterized by muscle stiffness and pain. It is believed that eperisone exerts its effect through inhibition of sodium channels. The drug is still being marketed in Asia under the name Myonal (Square Pharmaceuticals).
Originator
Approval Year
PubMed
ACTIVE MOIETY
SUBSTANCE RECORD
